April 20, 2021
Sale of Summa Equity's immunological reagents specialist HyTest moves into due diligence phase in William Blair-led process, signing expected before June according to sources close to the process (NKP Proprietary)
NKP | M&A Insights Proprietary
Headline from pre-deal coverage in M&A Insights